Milestone Pharmaceuticals Inc. (MIST) Form 8-K — Jun 15, 2026
$MISTForm 8-KItems 5.02, 5.07, 9.01Filed Jun 15, 2026, 8:00 AM ET0001104659-26-074025Original filing
Milestone Pharmaceuticals Inc. (MIST) reported the results of its 2026 annual meeting of shareholders held on June 10, 2026. Shareholders approved an amendment to the 2019 Equity Incentive Plan, increasing the number of ordinary shares authorized for issuance by 6,800,000 shares. The board of directors was re-elected with strong support, and shareholders ratified the appointment of PricewaterhouseCoopers LLP as the company’s auditor.
Key figures
- Total share reserve
- 23,592,722
- Shares authorized increase
- 6,800,000
- Votes for director election
- 23,437,235 to 24,212,031
- Votes for auditor ratification
- 75,025,285
- Votes against director election
- 3,146,845 to 3,921,639
- Votes for equity plan amendment
- 19,262,773
- Votes for executive compensation
- 19,665,705
- Votes against auditor ratification
- 249,836
- Votes against equity plan amendment
- 5,479,043
- Votes against executive compensation
- 6,990,920
Price after filing
1 day: -1.5%7 days: 0.0%30 days: -2.3%
Close on the filing date to close N calendar days later (from $1.31). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.